Lachlan H. Thompson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lachlan H. Thompson has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
C. Pavan
The Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne VIC 3010 Australia
1 shared publicationC.L. Parish
The Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne VIC 3010 Australia
1 shared publicationC.M. Sue
Neuroscience Research Australia and University of New South Wales, Sydney, NSW 2031, Australia
1 shared publicationCameron P.J. Hunt
The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia
1 shared publication- Clare L. Parish
Aligning Science Across Parkinson's (ASAP) Collaborative Research Network Chevy Chase Maryland USA
1 shared publication D. Kirik
University of Sydney, Sydney, NSW 2006, Australia; Lund University, Lund, 22184 Sweden
1 shared publication
Latest Publications
- Open Access
- 24 April 2025
- Published by Elsevier in Stem Cell Reports
- Vol. 20 (5) , 102480
Exercise promotes the functional integration of human stem cell-derived neural grafts in a rodent model of Parkinson’s disease
- 24 April 2025
- Published by Elsevier in Stem Cell Reports
- Vol. 20 (5) , 102480
Open AccessExercise promotes the functional integration of human stem cell-derived neural grafts in a rodent model of Parkinson’s disease
- Open Access
State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons
Dopaminergic neurons in the ventral tegmental area (VTA) and the substantia nigra pars compacta (SNpc) comprise around 75% of all dopaminergic neurons in the human brain. While both groups of dopaminergic neurons are in close proximity in the midbrain and partially overlap, development, function, and impairments in these two classes of neurons are highly diverse. The molecular and cellular mechanisms underlying these differences are not yet fully understood, but research over the past decade has highlighted the need to differentiate between these two classes of dopaminergic neurons during their development and in the mature brain. This differentiation is crucial not only for understanding fundamental circuitry formation in the brain but also for developing therapies targeted to specific dopaminergic neuron classes without affecting others. In this review, we summarize the state of the art in our understanding of the differences between the dopaminergic neurons of the VTA and the SNpc, such as anatomy, structure, morphology, output and input, electrophysiology, development, and disorders, and discuss the current technologies and methods available for studying these two classes of dopaminergic neurons, highlighting their advantages, limitations, and the necessary improvements required to achieve more-precise therapeutic interventions.
Open AccessState of the Art in Sub-Phenotyping Midbrain Dopamine Neurons
Dopaminergic neurons in the ventral tegmental area (VTA) and the substantia nigra pars compacta (SNpc) comprise around 75% of all dopaminergic neurons in the human brain. While both groups of dopaminergic neurons are in close proximity in the midbrain and partially overlap, development, function, and impairments in these two classes of neurons are highly diverse. The molecular and cellular mechanisms underlying these differences are not yet fully understood, but research over the past decade has highlighted the need to differentiate between these two classes of dopaminergic neurons during their development and in the mature brain. This differentiation is crucial not only for understanding fundamental circuitry formation in the brain but also for developing therapies targeted to specific dopaminergic neuron classes without affecting others. In this review, we summarize the state of the art in our understanding of the differences between the dopaminergic neurons of the VTA and the SNpc, such as anatomy, structure, morphology, output and input, electrophysiology, development, and disorders, and discuss the current technologies and methods available for studying these two classes of dopaminergic neurons, highlighting their advantages, limitations, and the necessary improvements required to achieve more-precise therapeutic interventions.
- Open Access
- 17 October 2023
- Published by Elsevier in Stem Cell Research
- Vol. 73, 103211
Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene
- 17 October 2023
- Published by Elsevier in Stem Cell Research
- Vol. 73, 103211
Open AccessGeneration of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene